Wildcard: BICO, Bioprinting, and Bioconvergence

<p>We get back to Wednesday's healthcare roots with a rundown on BICO Group, a Sweden-based business that enables researchers and scientists to model, build, test, analyze and observe 3-D printed cells, tissues and organs.</p> <p>This company helps researchers reduce the time and cost of identifying potentially efficacious drugs and can help provide initial results on whether drug compounds are safe and effective before<em data-stringify-type="italic"> </em>having to test them on animals or humans.</p> <p>We talk through the huge implications it could have for research in life sciences and personalized medicine and try to clear up some of the jargon around the company.</p> <p><strong>Stocks:</strong> (OM:BICO)</p> <p><strong>Check out more of our content here:</strong></p> <p><a href="https://www.fool.com/podcasts/"><span style= "font-weight: 400;">Podcasts</span></a></p> <p><a href= "https://www.youtube.com/user/TheMotleyFool"><span style="font-weight: 400;"> Youtube</span></a></p> <p><a href= "https://twitter.com/mfindustryfocus?lang=en"><span style= "font-weight: 400;">Twitter</span></a></p> <p><span style="font-weight: 400;">Reach us by Email @</span> <a href="http://IndustryFocus@fool.com"><span style= "font-weight: 400;">IndustryFocus@fool.com</span></a></p>